Skip to main content
. 2012 May 11;39(6):3089–3101. doi: 10.1118/1.4711909

Figure 1.

Figure 1

DVHs derived from the robustness quantification of the CTV and various OARs from the 36-beam IMPT-DET plan (left) and 3-beam IMPT-3D plan (right) with conventional PTV-based optimization for the prostate cancer case. The solid lines are the DVHs derived using the nominal dose of every voxel. All curves are normalized to the total volume of the corresponding organs.